
Sign up to save your podcasts
Or
Daniel Corcos, Ph.D. at Northwestern University, is running the first randomized control trial designed to investigate the effects of moderate- and high-intensity aerobic exercise on disease progression in untreated patients with Parkinson’s, called SPARX3. Listen as Dr. Corcos explains how aerobic exercise is a vital treatment for people living with Parkinson's.
4.3
4949 ratings
Daniel Corcos, Ph.D. at Northwestern University, is running the first randomized control trial designed to investigate the effects of moderate- and high-intensity aerobic exercise on disease progression in untreated patients with Parkinson’s, called SPARX3. Listen as Dr. Corcos explains how aerobic exercise is a vital treatment for people living with Parkinson's.
207 Listeners
141 Listeners
223 Listeners
181 Listeners
30 Listeners
27 Listeners
13 Listeners
16,249 Listeners
11 Listeners
28 Listeners
6 Listeners
6 Listeners
102 Listeners
5 Listeners
9 Listeners